(SMD: 1.32; 95% CI: 0.29, 2.35, P = 0.012, Fig. 2A), and chemerin levels were increased in NAFL patients relative to controls (SMD: 0.75; 95% CI: 0.01, 1.50; P = 0.047; Fig. 2B). This evidence concerns the gene RARRES2 and non-alcoholic fatty liver.